Company overview
Basic information
Company name
A investpharm, UAB
Company code
305987591
Registered address
Vilnius, A. Gustaičio g. 23-60, LT-02189
Registration date
2022-01-20
Company age: 4 y. 8 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
UAB "A investpharm"
Company code: 305987591
Address: Vilnius, A. Gustaičio g. 23-60, LT-02189
Download a detailed company report
Make confident decisions with all the information about A investpharm, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
A investpharm, UAB (company code 305987591) is an operational private limited liability company registered in 2022. It is classified as a private, Lithuanian-owned entity within the national private non-financial companies sector, with governance described as CEO only. The company is a micro business and operates from Vilnius, A. Gustaicio g. 23-60, Vilniaus m. sav., Vilniaus apskr. Its registered activity is retail sale of pharmaceutical products (EVRK G.47.73.00).
Financially, the company reported revenue of EUR 8.3K in 2025, down from EUR 23.5K in 2024 and EUR 18.2K in 2023. Net profit in 2025 was EUR 315, compared with EUR 2.5K in 2024 and EUR 574 in 2023, and the profit margin was 3.8% in 2025. At the end of 2025, equity stood at EUR 5.6K, liabilities at EUR 7.6K, and total assets at EUR 13.2K. The company’s capital is EUR 2.5K.
The workforce has remained small, with an average of 1 employee in 2023, 2024 and 2025, and 1 employee so far in 2026.
Financially, the company reported revenue of EUR 8.3K in 2025, down from EUR 23.5K in 2024 and EUR 18.2K in 2023. Net profit in 2025 was EUR 315, compared with EUR 2.5K in 2024 and EUR 574 in 2023, and the profit margin was 3.8% in 2025. At the end of 2025, equity stood at EUR 5.6K, liabilities at EUR 7.6K, and total assets at EUR 13.2K. The company’s capital is EUR 2.5K.
The workforce has remained small, with an average of 1 employee in 2023, 2024 and 2025, and 1 employee so far in 2026.